title: Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapies.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Vazquez-Martin
authors.forename: Silvia
authors.initials: S
authors.lastname: Cufí
authors.forename: Cristina
authors.initials: C
authors.lastname: Oliveras-Ferraros
authors.forename: Begoña
authors.initials: B
authors.lastname: Martin-Castillo
authors.forename: Sonia
authors.initials: S
authors.lastname: Del Barco
authors.forename: Eugeni
authors.initials: E
authors.lastname: López-Bonet
authors.forename: Javier A
authors.initials: JA
authors.lastname: Menendez
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D051017:Apoptosis Regulatory Proteins / Q000235:genetics*; D001343:Autophagy / Q000235:genetics; D000071186:Beclin-1; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D002273:Carcinogens; D002277:Carcinoma / Q000188:drug therapy* / Q000235:genetics; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D019008:Drug Resistance, Neoplasm; D005260:Female; D005784:Gene Amplification; D017353:Gene Deletion; D016147:Genes, Tumor Suppressor; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics*; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D051017:Apoptosis Regulatory Proteins; D000071186:Beclin-1; D002273:Carcinogens; D008565:Membrane Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C491997:BECN1 protein, human; C508053:ERBB2 protein, human